Science and Research

Open-label single-arm, multicenter clinical trial to evaluate patient acceptability of a new CREON formulation of Pancreas Powder gastro-resistant pellets in patients with cystic fibrosis suffering from pancreatic exocrine insufficiency. (PANC-GRP-3001)

The primary objective of the study is the Evaluation of acceptability of a new CREON sachet formulation containing Pancreas Powder gastro-resistant pellets for oral suspension. We included 11 patients, no drop out.

Study details
Study-ID: 2023-503256-27-00
DZL Disease Area: CFBE
DZL Disease Area: CFBE
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BIH / Charité - Associated Partner, CPC-M, TLRC
DZL Participating Sites: BIH / Charité - Associated Partner, CPC-M, TLRC
Start Date: 01.06.2024
Completion Date: 31.12.2024
Status: Closed
Status: Closed
DZL recruiting center


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.